Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

HISTORICAL FACTS: What to expect from charles river laboratories next quarterly earnings report - Caught on Camera

Valued at a market cap of $10.8 billion, Charles River Laboratories International, Inc. (CRL) is a global contract research organization (CRO) headquartered in Wilmington, Massachusetts. It supports the drug discovery and development process for pharmaceutical, biotechnology, medical device, and government clients worldwide. 

It is expected to announce its fiscal Q4 earnings for 2025 soon. Before this event, analysts expect this healthcare company to report a profit of $2.33 per share, down 12.4% from $2.66 per share in the year-ago quarter. The company has a promising trajectory of consistently beating Wall Street’s bottom-line estimates in each of the last four quarters. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.